 |
bispecific antibody (monoclonal antibody) |
|---|---|
| Trade Name | |
| Orphan Indication | HER2-expressing advanced adenocarcinoma of the stomach and gastroesophageal junction |
| USA Market Approval | USA |
| USA Designation Date | 2013-08-08 00:00:00 |
| Sponsor | Merrimack Pharmaceuticals, inc.;One Kendall Square, Suite B7201;Cambridge, Massachusetts, 02139 |
